Table 3.
Lethality comparison between waves and the interwave period among hospitalized patients with COVID-19
| Age group | Comorbidities | CFR-interwave | CFR-waves | Difference-CFR | Fisher exact test FDR* |
|---|---|---|---|---|---|
| 20,39 |
None |
7.91 |
11.65 |
3.74 |
1.42x10-5 |
| 20,39 |
Obes |
13.00 |
18.21 |
5.21 |
1.50x10-2 |
| 20,39 |
DM, AHP |
16.07 |
32.55 |
16.48 |
3.37x10-2 |
| 20,39 |
DM, Obes |
13.46 |
28.76 |
15.30 |
4.48x10-2 |
| 40,59 |
None |
20.37 |
29.72 |
9.34 |
2.29x10-27 |
| 40,59 |
Obes |
22.35 |
33.79 |
11.45 |
1.30x10-11 |
| 40,59 |
DM, AHP, Obes |
27.72 |
42.02 |
14.30 |
1.65x10-6 |
| 40,59 |
AHP |
25.57 |
35.33 |
9.76 |
2.35x10-6 |
| 40,59 |
DM, AHP |
32.86 |
42.33 |
9.47 |
2.35x10-6 |
| 40,59 |
AHP, Obes |
26.04 |
37.69 |
11.64 |
5.00x10-5 |
| 40,59 |
DM |
30.10 |
38.08 |
7.98 |
6.81x10-5 |
| 40,59 |
DM, Obes |
26.72 |
38.52 |
11.80 |
1.20x10-3 |
| 40,59 |
Other |
24.36 |
29.15 |
4.79 |
2.51x10-2 |
| 60,79 |
None |
40.85 |
49.89 |
9.04 |
8.82x10-16
|
| 60,79 |
DM |
41.51 |
53.41 |
11.90 |
3.35x10-10 |
| 60,79 |
AHP |
41.01 |
50.55 |
9.54 |
3.64x10-9 |
| 60,79 |
Obes |
39.41 |
52.80 |
13.39 |
2.35x10-6 |
| 60,79 |
DM, AHP |
46.79 |
53.64 |
6.84 |
2.35x10-6 |
| 60,79 |
Other |
39.07 |
47.82 |
8.75 |
1.02x10-4 |
| 60,79 |
DM, AHP, Obes |
45.36 |
54.21 |
8.85 |
4.10x10-4 |
| 60,79 |
DM, Obes |
39.81 |
54.26 |
14.45 |
7.39x10-4 |
| 60,79 |
AHP, Obes |
46.10 |
52.27 |
6.16 |
4.48x10-2 |
| 80+ |
None |
50.47 |
59.02 |
8.55 |
8.76x10-4 |
| 80+ | DM, AHP | 51.75 | 58.02 | 6.27 | 4.48x10-2 |
DM – diabetes mellitus, AHP – arterial hypertension, Obes – obesity, CFR-wave – cases occurred in either peak, Difference-CFR – the difference between CFR-wave and CFR-interwave, CFR-interwave – cases occurred during the period interpeak, FDR – Fisher exact test
*Fisher exact test with Benjamini-Hochberg (BH) correction was used to estimate difference. FDR<0.05 – statistically significant value.